Zinc aspartate suppresses T cell activation in vitro and relapsing experimental autoimmune encephalomyelitis in SJL/J mice. (Q53659351)

16 May 2018

title

Zinc aspartate suppresses T cell activation in vitro and relapsing experimental autoimmune encephalomyelitis in SJL/J mice. (English)

1 reference

16 May 2018

experimental autoimmune encephalomyelitis

main subject

1 reference

Diana Stoye

1

1 reference

16 May 2018

Claudia Schubert

2

1 reference

16 May 2018

Alexander Goihl

3

1 reference

16 May 2018

Karina Guttek

4

1 reference

16 May 2018

Annegret Reinhold

5

1 reference

16 May 2018

Stefan Brocke

6

1 reference

16 May 2018

Kurt Grüngreiff

7

1 reference

16 May 2018

Dirk Reinhold

8

1 reference

16 May 2018

publication date

19 February 2012

1 reference

16 May 2018

published in

BioMetals

1 reference

16 May 2018

volume

25

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

529-539

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1007/s10534-012-9532-z

exact match

0 references

cites work

T(H)-17 cells in the circle of immunity and autoimmunity

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

The physiological role of zinc as an antioxidant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Zinc at pharmacologic concentrations affects cytokine expression and induces apoptosis of human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Genetics of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Zinc in pharmacological doses suppresses allogeneic reaction without affecting the antigenic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Statistical analysis of data from studies on experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Zinc homeostasis and signaling in health and diseases: Zinc signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Immunopathogenesis and immunotherapy of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Zinc signals promote IL-2-dependent proliferation of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Zinc deficiency and immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Zinc suppresses Th17 development via inhibition of STAT3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

RETRACTED: Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Anaemia and low serum-copper during zinc therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Effects of zinc deficiency on Th1 and Th2 cytokine shifts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Hypocupremia Induced by Zinc Therapy in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Antioxidant effect of zinc in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

PETIR-001, a dual inhibitor of dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN), ameliorates experimental autoimmune encephalomyelitis in SJL/J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Th17: an effector CD4 T cell lineage with regulatory T cell ties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

IL-17 family cytokines and the expanding diversity of effector T cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

The immunobiology of zinc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Zinc is a novel intracellular second messenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

Regulation of T cell receptor signaling by activation-induced zinc influx

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9532-Z

10.1007/S10534-012-9532-Z

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

22350510

1 reference

16 May 2018